氯吡格雷代替低分子肝素钠治疗冠状动脉内支架植入(PCI)术后患者疗效观察及护理研究  

Investig ation on Effects and Nusing of Clopidogree or Low Molecular Aeparin on Patients after Percutaneons Coronary Intervention Treatment

作　　者：林惠[1] 蔡靳[1] 

机构地区：[1]四川省内江市第一人民医院,641000

出　　处：《中国医药指南》2009年第5期30-31,共2页Guide of China Medicine

摘　　要：目的观察氯吡格雷低分子肝素钠治疗PCI患者的临床疗效及护理分析。方法将86例PCI患者随机分为氯吡格雷治疗组和低分子肝素钠对照组。观察两组患者用药的接受程度,疗效不良反应及预防再次发生心脏事件的发生率,包括再梗死、猝死,不稳定型心绞痛、脑卒中等。结果氯吡格雷临床效果好,心绞痛,再次心肌梗死发作明显减少、死亡脑卒中的联合终点也显著下降[1],患者用药无痛苦,避免反复注射,引起皮下出血等。结论氯吡格雷用于PCI术后患者具有方便,并发症少及不良反应轻微的优点、安全耐受性好。Objective To observe the effects ahd nursing of clopidogrel or Low nlolecuLar He parin （LMA） on pntients after percutaneous coronavy intervention treatment. Methods Eighty-sixpatients with Acs were divided randomly into clopiologree qroup and Lma gronp the attacks of postinfarction angina pectoris events of heart failare and the composite of death reinfarction or stroke were observed. Results Compared with clopidogrel group patients of clopiologree had obvious reduction in the attacks of postinf arction angina pectoris and the composite of death reinfarction or stroke P〈0.05. Furth more the patients of clopiologree group suffered little pain and bleedings and avoid infection. Conclusions Patients with clopidogret after percutaneons coronary intervention treatment had good guality of convenience little had effevt and complication and better tore lance.

关 键 词：氯吡格雷 低分子肝素钠 PCI 护理研究 

分 类 号：R472[医药卫生—护理学]